ImmunoMet Therapeutics

0 followers

‌

ImmunoMet Therapeutics is a clinical stage biotech targeting cellular metabolism to develop novel anti-fibrotic and anti-tumor therapies.

Industries

Biotechnology

Headquarters

Houston, United States

Employees

1-10

Links

Org chart

Dean Welsch

Chief Executive Officer

Tingchen Cui

Co-chief Executive Officer

Teams

Leadership Team

0 members

Offices

This company has no offices yet

Similar companies

Thermo Fisher Scientific

173 followers

Genentech

159 followers

Biogen

119 followers

Amyris

9 followers

PerkinElmer

9 followers

Promega

9 followers

Stemline Therapeutics

3 followers

Merck

226 followers

Generation Bio

2 followers

Celldex Therapeutics

2 followers

Immunome

2 followers

Explore companies

��������